This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Singapore Health Services Pte Ltd. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Swee Lim Gary Peh: Innovator in Corneal Endothelial Cell Culture
Introduction
Swee Lim Gary Peh is a notable inventor based in Singapore, recognized for his contributions to the field of cell culture. His innovative work focuses on the cultivation of corneal endothelial cells, which are crucial for maintaining corneal transparency and overall eye health.
Latest Patents
Swee Lim Gary Peh holds a patent for a groundbreaking invention titled "Cell culture of corneal endothelial cells." This invention introduces a dual-media approach for culturing isolated corneal endothelial cells. The process involves initially using a proliferative medium to propagate and expand the endothelial cells, followed by a maintenance medium to preserve their morphology and characteristics. This innovative method enhances the viability and functionality of corneal endothelial cells, which can have significant implications for eye treatments.
Career Highlights
Swee Lim Gary Peh is affiliated with Singapore Health Services Pte Ltd, where he applies his expertise in cell culture and regenerative medicine. His work has contributed to advancements in ophthalmology and has the potential to improve therapeutic options for patients with corneal diseases.
Collaborations
Some of his notable coworkers include Donald Tan and Jodhbir Singh Mehta, who collaborate with him on various research projects aimed at enhancing eye health and treatment methodologies.
Conclusion
Swee Lim Gary Peh's innovative approach to culturing corneal endothelial cells represents a significant advancement in the field of regenerative medicine. His contributions are paving the way for improved treatments in ophthalmology, showcasing the importance of innovation in healthcare.